Sort
48,018 grants matching “immunotherapy”
Evaluation of therapeutic efficacy in mouse melenoma models
$722,593Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Project 1 - Evolutionary and ecological dynamics of tumor-host interactions
$722,451Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
$722,385Isaac P Thomsen · Vanderbilt University Medical Center · R01 · FY2021 · AI
Immunobiology of Normal and Neoplastic Lymphocytes
$722,337Warren S Pear · University Of Pennsylvania · T32 · FY2022 · CA
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
$722,240Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Development of lung T cell responses in infant respiratory immunity
$722,112Donna L Farber · Columbia University Health Sciences · R01 · FY2015 · AI
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
$721,946Carol A Kruse · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid Leukemia
$721,888Pietro Genovese · Boston Children'S Hospital · R01 · FY2025 · CA
The role of the innate immune system on Treg reprogramming in human autoimmune di
$721,853David A. Hafler · Yale University · U01 · FY2016 · AI
Immune and transcriptomic biomarkers of progressive oral premalignant lesions
$721,826Fatemeh Momen Heravi · University Of California, San Francisco · U01 · FY2024 · DE
Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation
$721,723Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAH
$721,683Marlene Rabinovitch · Stanford University · R01 · FY2019 · HL
GCDH Addiction in Melanoma
$721,672Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Southeast Pediatric AIDS Clinical Trials Unit
$721,600University Of Alabama At Birmingham · U01 · FY2002 · AI
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies
$721,590Rebecca Marie Lynch · George Washington University · R01 · FY2024 · AI
Guinea pig model for TB vaccine evaluations
$721,424Colorado State University-Fort Collins · R01 · FY2005 · AI
Mechanisms of cancer immunotherapy-associated thrombosis
$721,398Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL
Project 3: Hyperimmune globulin prophylaxis and treatment of ZIKV in pregnancy
$721,231David H Oconnor · University Of Wisconsin-Madison · P01 · FY2021 · AI
Personalized vaccine for patients with AML
$721,179David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$721,121Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
$721,035Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer
$720,945Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2019 · CA
Stratifying Patient Immune Endotypes in Sepsis (SPIES Study)
$720,877Robert Maile · University Of Florida · R01 · FY2024 · GM
Advancing the translatability of mouse models for cancer immunotherapy
$720,801Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2020 · CA
Mechanisms of cancer immunotherapy-associated thrombosis
$720,736Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL